1. Home
  2. CDNA vs VSAT Comparison

CDNA vs VSAT Comparison

Compare CDNA & VSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDNA
  • VSAT
  • Stock Information
  • Founded
  • CDNA 1998
  • VSAT 1986
  • Country
  • CDNA United States
  • VSAT United States
  • Employees
  • CDNA N/A
  • VSAT N/A
  • Industry
  • CDNA Medical Specialities
  • VSAT Radio And Television Broadcasting And Communications Equipment
  • Sector
  • CDNA Health Care
  • VSAT Technology
  • Exchange
  • CDNA Nasdaq
  • VSAT Nasdaq
  • Market Cap
  • CDNA 1.1B
  • VSAT 1.1B
  • IPO Year
  • CDNA 2014
  • VSAT 1996
  • Fundamental
  • Price
  • CDNA $22.34
  • VSAT $11.50
  • Analyst Decision
  • CDNA Buy
  • VSAT Buy
  • Analyst Count
  • CDNA 8
  • VSAT 7
  • Target Price
  • CDNA $26.43
  • VSAT $19.00
  • AVG Volume (30 Days)
  • CDNA 751.5K
  • VSAT 4.1M
  • Earning Date
  • CDNA 02-26-2025
  • VSAT 02-04-2025
  • Dividend Yield
  • CDNA N/A
  • VSAT N/A
  • EPS Growth
  • CDNA N/A
  • VSAT N/A
  • EPS
  • CDNA N/A
  • VSAT N/A
  • Revenue
  • CDNA $312,775,000.00
  • VSAT $4,527,274,000.00
  • Revenue This Year
  • CDNA $19.85
  • VSAT $7.71
  • Revenue Next Year
  • CDNA $11.34
  • VSAT $1.73
  • P/E Ratio
  • CDNA N/A
  • VSAT N/A
  • Revenue Growth
  • CDNA 5.26
  • VSAT 36.25
  • 52 Week Low
  • CDNA $7.42
  • VSAT $6.69
  • 52 Week High
  • CDNA $34.84
  • VSAT $26.70
  • Technical
  • Relative Strength Index (RSI)
  • CDNA 48.07
  • VSAT 62.38
  • Support Level
  • CDNA $22.06
  • VSAT $7.45
  • Resistance Level
  • CDNA $23.56
  • VSAT $12.55
  • Average True Range (ATR)
  • CDNA 1.79
  • VSAT 1.00
  • MACD
  • CDNA 0.07
  • VSAT 0.35
  • Stochastic Oscillator
  • CDNA 25.72
  • VSAT 79.41

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.

About VSAT ViaSat Inc.

Viasat Inc provides bandwidth technologies and services in three segments: satellite services: which provides satellite-based high-speed broadband services to consumers, enterprises, and commercial airlines; commercial networks: which develops end-to-end communication and connectivity systems; and government systems: which produces network-centric Internet Protocol-based secure government communication systems. A large majority of the firm's revenue is generated in the United States, it also has its presence in non U.S. countries.

Share on Social Networks: